01-Jul-2026 11:46:29
JBCHEPHARMGeneral news
TORRENT PHARMA : CORPORATE FILING
• Declaration regarding no encumbrance on shares of J.B. Chemicals & Pharmaceuticals Limited. • Filed pursuant to Regulation 31 (4) of SEBI (SAST) Regulations, 2011. • Applicable for the financial year ended 31st March, 2026. • Stated that no encumbrance was made, directly or indirectly, during the said period. Impact: Neutral (Standard disclosure filing)
JB Chemicals & Pharmaceuticals Limited
Open attachment